Residual structure and dynamics in Parkinson's disease-associated mutants of alpha-synuclein
- PMID: 11590151
- DOI: 10.1074/jbc.M106777200
Residual structure and dynamics in Parkinson's disease-associated mutants of alpha-synuclein
Abstract
alpha-Synuclein (alpha S) is a pre-synaptic protein that has been implicated as a possible causative agent in the pathogenesis of Parkinson's disease (PD). Two autosomal dominant missense mutations in the alpha S gene are associated with early onset PD. Because alpha S is found in an aggregated fibrillar form in the Lewy body deposits characteristic of Parkinson's patients, aggregation of the protein is believed to be related to its involvement in the disease process. The wild type (WT) and early onset mutants A30P and A53T display diverse in vitro aggregation kinetics even though the gross physicochemical and morphological properties of the mutants are highly similar. We used high resolution solution NMR spectroscopy to compare the structural and dynamic properties of the A53T and A30P mutants with those of WT alpha S in the free state. We found that the A30P mutation disrupts a region of residual helical structure that exists in the WT protein, whereas the A53T mutation results in a slight enhancement of a small region around the site of mutation with a preference for extended conformations. Based on these results and on the anticipated effects of these mutations on elements of secondary structure, we proposed a model of how these two PD-linked mutations influence alpha S fibril formation that is consistent with the documented differences in the fibrillization kinetics of the two mutants.
Similar articles
-
Effects of Parkinson's disease-linked mutations on the structure of lipid-associated alpha-synuclein.Biochemistry. 2004 Apr 27;43(16):4810-8. doi: 10.1021/bi036135+. Biochemistry. 2004. PMID: 15096050
-
Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein.Biochemistry. 2001 Sep 25;40(38):11604-13. doi: 10.1021/bi010616g. Biochemistry. 2001. PMID: 11560511
-
Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.Biochemistry. 2000 Mar 14;39(10):2552-63. doi: 10.1021/bi991447r. Biochemistry. 2000. PMID: 10704204
-
Alpha-synuclein aggregation and neurodegenerative diseases.J Alzheimers Dis. 2003 Apr;5(2):139-48. doi: 10.3233/jad-2003-5208. J Alzheimers Dis. 2003. PMID: 12719631 Review.
-
Amino acid determinants of alpha-synuclein aggregation: putting together pieces of the puzzle.FEBS Lett. 2002 Jul 3;522(1-3):9-13. doi: 10.1016/s0014-5793(02)02883-1. FEBS Lett. 2002. PMID: 12095610 Review.
Cited by
-
NMR of alpha-synuclein-polyamine complexes elucidates the mechanism and kinetics of induced aggregation.EMBO J. 2004 May 19;23(10):2039-46. doi: 10.1038/sj.emboj.7600211. Epub 2004 Apr 22. EMBO J. 2004. PMID: 15103328 Free PMC article.
-
The C-terminus of α-Synuclein Regulates its Dynamic Cellular Internalization by Neurexin 1β.Mol Biol Cell. 2023 Dec 1;34(13):br21. doi: 10.1091/mbc.E22-11-0496. Epub 2023 Sep 20. Mol Biol Cell. 2023. PMID: 37729016 Free PMC article.
-
The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of α-synuclein, and enhances its secretion and nuclear localization in cells.Hum Mol Genet. 2014 Sep 1;23(17):4491-509. doi: 10.1093/hmg/ddu165. Epub 2014 Apr 11. Hum Mol Genet. 2014. PMID: 24728187 Free PMC article.
-
Alpha-Synuclein Post-translational Modifications: Implications for Pathogenesis of Lewy Body Disorders.Front Aging Neurosci. 2021 Jun 25;13:690293. doi: 10.3389/fnagi.2021.690293. eCollection 2021. Front Aging Neurosci. 2021. PMID: 34248606 Free PMC article. Review.
-
Effect of the A30P mutation on the structural dynamics of micelle-bound αSynuclein released in water: a molecular dynamics study.Eur Biophys J. 2012 May;41(5):483-9. doi: 10.1007/s00249-012-0803-y. Epub 2012 Mar 24. Eur Biophys J. 2012. PMID: 22446722
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous